Stephen Rocamboli - May 23, 2024 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Sheldon L. Koenig, by power of attorney
Stock symbol
ESPR
Transactions as of
May 23, 2024
Transactions value $
$0
Form type
4
Date filed
5/24/2024, 04:15 PM
Previous filing
Apr 22, 2024
Next filing
Jul 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Award $0 +23K +173.44% $0.00 36.3K May 23, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ESPR Stock Option (right to buy) Award $0 +32.5K $0.00 32.5K May 23, 2024 Common Stock 32.5K $2.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The awards vest in full on the earlier of (i) May 23, 2025 and (ii) the Issuer's next annual meeting of stockholders following May 23, 2024.